Key facts
- This page summarizes Thomas Ebeling's Form 4 filing for Cullinan Therapeutics, Inc. (CGEM).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 11 Jun 2024, 18:00.
Thomas Ebeling - 10 Jun 2024 Form 4 Insider Report for Cullinan Therapeutics, Inc. (CGEM)
- Reporting relationship
- Director
- Issuer ticker
- CGEM
- Reported as of
- 10 Jun 2024
- Net transaction value
- +$239,850
- SEC form
- 4
- Accepted by SEC
- 11 Jun 2024, 18:00:03 UTC
- Prior SEC filing
- 23 May 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jacquelyn Sumer, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Thomas Ebeling filed Form 4 for Cullinan Therapeutics, Inc. (CGEM) on 11 Jun 2024.
Change
- Previous filing in this sequence was filed on 23 May 2024.
- Current net transaction value: +$239,850.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CGEM
transaction
Common Stock
Options Exercise
- Transaction value
- $239,850
- Shares
- +18,450
- Change %
- +11%
- Price
- $13.00
- Shares after
- 186,653
- Date
- 10 Jun 2024
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CGEM
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -18,450
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 10 Jun 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 18,450
- Exercise price
- $13.00
* marks a reported price that did not pass the local price check.